FI49162C - Menetelmä terapeuttisesti käytettävien 3-indolyyli-alifaattinen-happo- johdannaisten valmistamiseksi. - Google Patents

Menetelmä terapeuttisesti käytettävien 3-indolyyli-alifaattinen-happo- johdannaisten valmistamiseksi.

Info

Publication number
FI49162C
FI49162C FI670074A FI7467A FI49162C FI 49162 C FI49162 C FI 49162C FI 670074 A FI670074 A FI 670074A FI 7467 A FI7467 A FI 7467A FI 49162 C FI49162 C FI 49162C
Authority
FI
Finland
Prior art keywords
indolyl
preparation
acid derivatives
aliphatic acid
therapeutically useful
Prior art date
Application number
FI670074A
Other languages
English (en)
Swedish (sv)
Inventor
Hisao Yamamoto
Masaru Nakao
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Application granted granted Critical
Publication of FI49162C publication Critical patent/FI49162C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72—Hydrazones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B19/00—Liquid-phase epitaxial-layer growth
    • C30B19/02—Liquid-phase epitaxial-layer growth using molten solvents, e.g. flux
    • C30B19/04—Liquid-phase epitaxial-layer growth using molten solvents, e.g. flux the solvent being a component of the crystal composition
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B19/00—Liquid-phase epitaxial-layer growth
    • C30B19/06—Reaction chambers; Boats for supporting the melt; Substrate holders
    • C30B19/061—Tipping system, e.g. by rotation
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
    • C30B29/10—Inorganic compounds or compositions
    • C30B29/40—AIIIBV compounds wherein A is B, Al, Ga, In or Tl and B is N, P, As, Sb or Bi
    • C30B29/42—Gallium arsenide
FI670074A 1966-01-12 1967-01-12 Menetelmä terapeuttisesti käytettävien 3-indolyyli-alifaattinen-happo- johdannaisten valmistamiseksi. FI49162C (fi)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
JP199966 1966-01-12
JP2730066 1966-04-28
JP2730166 1966-04-28
JP2812566 1966-05-02
JP2840066 1966-05-04
JP4059166 1966-06-21
JP4472366 1966-07-08
JP4472466 1966-07-08
JP5467566 1966-08-19
JP5467466 1966-08-19

Publications (1)

Publication Number Publication Date
FI49162C true FI49162C (fi) 1975-04-10

Family

ID=27579471

Family Applications (1)

Application Number Title Priority Date Filing Date
FI670074A FI49162C (fi) 1966-01-12 1967-01-12 Menetelmä terapeuttisesti käytettävien 3-indolyyli-alifaattinen-happo- johdannaisten valmistamiseksi.

Country Status (13)

Country Link
AT (4) AT277995B (fi)
BE (1) BE692456A (fi)
BR (1) BR6786134D0 (fi)
CS (3) CS155158B2 (fi)
DE (2) DE1620441C3 (fi)
DK (1) DK134715B (fi)
FI (1) FI49162C (fi)
FR (1) FR7844M (fi)
IL (1) IL27173A (fi)
NL (1) NL146804B (fi)
NO (3) NO126862B (fi)
SE (2) SE314985B (fi)
SU (1) SU375847A3 (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU162374B (fi) * 1969-04-03 1973-02-28
CZ300116B6 (cs) * 2006-12-05 2009-02-11 Zentiva, A. S. Zpusob cištení hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu

Also Published As

Publication number Publication date
SU375847A3 (fi) 1973-03-23
NO126864B (fi) 1973-04-02
CS155156B2 (fi) 1974-05-30
DE1620441C3 (de) 1975-05-22
AT280991B (de) 1970-05-11
AT277996B (de) 1970-01-12
AT277995B (de) 1970-01-12
DK134715B (da) 1977-01-03
NL6700300A (fi) 1967-07-13
NO126865B (fi) 1973-04-02
DE1618933A1 (de) 1972-03-16
DE1620441B2 (de) 1974-09-19
BR6786134D0 (pt) 1973-12-26
BE692456A (fi) 1967-06-16
NL146804B (nl) 1975-08-15
FR7844M (fi) 1970-06-01
DK134715C (fi) 1977-05-31
IL27173A (en) 1972-08-30
CS155157B2 (fi) 1974-05-30
NO126862B (fi) 1973-04-02
DE1643506A1 (de) 1972-03-30
DE1620441A1 (de) 1970-08-27
AT283349B (de) 1970-08-10
DE1643506B2 (de) 1973-01-04
SE314985B (fi) 1969-09-22
CS155158B2 (fi) 1974-05-30
SE307795B (fi) 1969-01-20

Similar Documents

Publication Publication Date Title
FI48590C (fi) Menetelmä terapeuttisesti käytettävien atsaspiroalkaanidioniyhdisteide n valmistamiseksi.
FI49035C (fi) Menetelmä terapeuttisesti käytettävän 2-bromi-alfa-ergokryptiinin valm istamiseksi.
FI51046C (fi) Menetelmä asetosalisyylihappotabletin valmistamiseksi.
DK120749B (da) Analogifremgangsmåde til fremstilling af 6-aminopenicillansyrederivater.
FI52335C (fi) Menetelmä terapeuttisesti vaikuttavien trisyklisten etyyliamiini-johda nnaisten valmistamiseksi.
FI46373C (fi) Menetelmä fenyyliaminopropaanin uusien terapeuttisesti käyttökelpoiste n johdannaisten valmistamiseksi.
FI45447C (fi) Menetelmä terapeuttisesti aktiivisten imidatsolijohdannaisten valmista miseksi
FI47365C (fi) Menetelmä valmistaa uusia terapeuttisesti vaikuttavia indolijohdannais ia.
FI49512C (fi) Menetelmä uusien terapeuttisesti aktiivisten s-triatsinyylipiperatsiin ijohdannaisten valmistamiseksi.
FI50409C (fi) Menetelmä pyridiini-karboksyylihappojen valmistamiseksi
FI48728C (fi) Analogiamenetelmä terapeuttisesti käytettävien fenyylietikkahappojohda nnaisten valmistamiseksi.
FI45041C (fi) Menetelmä terapeuttisesti käyttökelpoisten pyrroli-johdannaisten valmi stamiseksi.
FI46501C (fi) Menetelmä terapeuttisesti aktiivisten, substituoitujen fenyylietikkaha ppoestereiden valmistamiseksi.
FI45551C (fi) Menetelmä terapeuttisesti käytettävän dehydroepiandrosteroniönantaatin valmistamiseksi.
FI46154C (fi) Menetelmä terapeuttisesti käytettävien diaminobentsofenonien ja niiden happoadditiosuolojen valmistamiseksi.
FI46961C (fi) Menetelmä terapeuttisesti aktiivisten 5-nitroimidatsolikarbamaattien v almistamiseksi
FI47881C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen fenyyliasetamidi en valmistamiseksi
FI48576C (fi) Menetelmä terapeuttisesti aktiivisten alfa-fluori-malonihappojohdannai sten valmistamiseksi.
FI47189C (fi) Tapa valmistaa terapeuttisesti vaikuttavia d-lysergiinihappo-N-fenyyli piperatsideja.
FI49308C (fi) Menetelmä 6-aminopenisillaanihapon valmistamiseksi.
FI49162C (fi) Menetelmä terapeuttisesti käytettävien 3-indolyyli-alifaattinen-happo- johdannaisten valmistamiseksi.
FI52577C (fi) Menetelmä terapeuttisesti käytettävien fenatsiinijohdannaisten valmist amiseksi.
FI47092C (fi) Menetelmä terapeuttisesti arvokkaiden sekasubstituoitujen 1-fenoksi-3- alkyyliaminopropanolien-(2) valmistamiseksi.
FI48190C (fi) Menetelmä terapeuttisesti aktiivisten 10alfa-metoksi-9,10-dihydroergol iinijohdannaisten valmistamiseksi
FI45045C (fi) Menetelmä uusien terapeuttisesti vaikuttavien 5-nitro-2-furyyli-isoksa tsolijohdannaisten valmistamiseksi.